Pharma Failures & IT Raids Linked to Electoral Bonds

According to the data released by the Election Commission, almost thirty-five pharmaceutical companies in India contributed Rs 1,000 crore to political parties through electoral bonds

Sun Pharmaceuticals' Winlevi Granted Approval for Distribution in Australia

Sun Pharmaceutical Industries Limited has recently announced that the Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for Winlevi, a clascoterone cream.

Univ of Calgary Joins Phase II LSALT Trial for Cardiac Surgery Kidney Injury

Arch Biopartners Inc, a late-stage clinical trial company focused on preventing inflammation and acute organ injury

Indian Pharma Embraces UCPMP Guidelines for Ethical Marketing

The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 guidelines have been recently released, and the Indian pharmaceutical sector sees it as a practical approach to promoting ethical marketing practices in the country.

FDA Approves Rezdiffra for Noncirrhotic NASH with Liver Fibrosis

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company specializing in developing novel therapeutics for NASH, has announced that the US Food and Drug Administration (FDA) has granted accelerated approval for Rezdiffra

Government Initiatives: Enhancing Healthcare Access for the Elderly people

Forty-nine district hospitals have established geriatric wards in the past three months to cater to patients requiring specialized care. These hospitals have also introduced geriatric clinics for elderly patients seeking OPD services.

Netskope Report: Infostealers Target Patient Data in Healthcare Sector

The healthcare sector has been one of the areas most affected by the 2023 mega breaches, which saw over a million records stolen.

Sakra Hospital Expands: Second Bengaluru Facility at Rs 1,000 Crore

Sakra World Hospital, a joint venture between SECOM and Toyota Tsusho Corporation (TTC), has announced plans to establish a healthcare facility in Banaswadi, Bengaluru, with an expected investment of Rs 1,000 crore.

Modi Removes Constitutional Barriers, Improves J&K Healthcare: Dr. Jitendra

Union Minister Dr Jitendra Singh recently addressed the “Doctors’ Sammelan” organized by BJP, where he shared his perspective on the challenges faced by the healthcare sector in Jammu & Kashmir.

US Business Growth Boosts Pharma Companies

For the past eighteen months, Gujarat's pharmaceutical companies have been grappling with concerns over price erosion in the US market. However, recent developments indicate a welcome resurgence in their US market revenues.

© 2025 India Pharma Outlook. All Rights Reserved.